Outcome measures for Alzheimer's disease: A global inter‐societal Delphi consensus
Alzheimer's & Dementia · 2023-06 · 19 (6) · 2707-2729
DOI: 10.1002/alz.12945 ↗Kurz gefasst
Delphi-Studie in der Zeitschrift Alzheimer's & Dementia, online erschienen am 07.02.2023. Verfasst von Tim S Ellison und 21 weiteren Autor:innen. Beteiligte Einrichtung: PharmaGenesis London, London, UK. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Introduction
We aim to provide guidance on outcomes and measures for use in patients with Alzheimer's clinical syndrome.
Methods
A consensus group of 20 voting members nominated by 10 professional societies, and a non‐voting chair, used a Delphi approach and modified GRADE criteria.
Results
Consensus was reached on priority outcomes ( n = 66), measures ( n = 49) and statements ( n = 37) across nine domains. A number of outcomes and measurement instruments were ranked for: Cognitive abilities; Functional abilities/dependency; Behavioural and neuropsychiatric symptoms; Patient quality of life (QoL); Caregiver QoL; Healthcare and treatment‐related outcomes; Medical investigations; Disease‐related life events; and Global outcomes.
Discussion
This work provides indications on the domains and ideal pertinent measurement instruments that clinicians may wish to use to follow patients with cognitive impairment. More work is needed to develop instruments that are more feasible in the context of the constraints of clinical routine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- PharmaGenesis London, London, UK.
- Scuola Universitaria Superiore IUSS Pavia, Pavia, Italy.
- Dementia Research Center, IRCCS Mondino Foundation, Pavia, Italy.
- Royal College of Nursing, London, UK.
- Alzheimer Europe, Luxembourg, Luxembourg.
- Unit for Early and Exploratory Clinical Development, The University of Tokyo Hospital, Tokyo, Japan.
Förderung
- NIA NIH HHS
Zitieren
APA
Ellison, T. S., Cappa, S. F., Garrett, D., Georges, J., Iwatsubo, T., Kramer, J. H., Lehmann, M., Lyketsos, C., Maier, A. B., Merrilees, J., Morris, J. C., Naismith, S. L., Nobili, F., Pahor, M., Pond, D., Robinson, L., Soysal, P., Vandenbulcke, M., Weber, C. J., …, & Frisoni, G. B. (2023). Outcome measures for Alzheimer's disease: A global inter‐societal Delphi consensus. Alzheimer's & Dementia, 19(6), 2707-2729. https://doi.org/10.1002/alz.12945
Vancouver
Ellison TS, Cappa SF, Garrett D, Georges J, Iwatsubo T, Kramer JH, et al. Outcome measures for Alzheimer's disease: A global inter‐societal Delphi consensus. Alzheimer's & Dementia. 2023;19(6):2707-2729. doi:10.1002/alz.12945
BibTeX
@article{Ellison2023,
author = {Ellison, Tim S and Cappa, Stefano F and Garrett, Dawne and Georges, Jean and Iwatsubo, Takeshi and Kramer, Joel H and Lehmann, Maryna and Lyketsos, Constantine and Maier, Andrea B and Merrilees, Jennifer and Morris, John C and Naismith, Sharon L and Nobili, Flavio and Pahor, Marco and Pond, Dimity and Robinson, Louise and Soysal, Pinar and Vandenbulcke, Mathieu and Weber, Christopher J and Visser, Pieter Jelle and Weiner, Michael and Frisoni, Giovanni B},
title = {Outcome measures for Alzheimer's disease: A global inter‐societal Delphi consensus},
journal = {Alzheimer's & Dementia},
year = {2023},
volume = {19},
number = {6},
pages = {2707--2729},
doi = {10.1002/alz.12945}
}
EUVIMED